nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—DNMT3A—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0521	0.205	CbGpPWpGaD
Decitabine—DNMT1—Trans-sulfuration and one carbon metabolism—DNMT3L—testicular cancer	0.0352	0.138	CbGpPWpGaD
Decitabine—DNMT3A—DNA methylation—DNMT3L—testicular cancer	0.0307	0.121	CbGpPWpGaD
Decitabine—DNMT3A—embryo—testicular cancer	0.0259	0.123	CbGeAlD
Decitabine—DNMT3A—seminal vesicle—testicular cancer	0.0243	0.116	CbGeAlD
Decitabine—DNMT1—DNA methylation—DNMT3L—testicular cancer	0.0207	0.0816	CbGpPWpGaD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.0179	0.0703	CbGpPWpGaD
Decitabine—DNMT3A—gonad—testicular cancer	0.0176	0.0836	CbGeAlD
Decitabine—DNMT1—embryo—testicular cancer	0.0156	0.0745	CbGeAlD
Decitabine—DNMT1—seminal vesicle—testicular cancer	0.0147	0.07	CbGeAlD
Decitabine—DNMT3A—female gonad—testicular cancer	0.0143	0.0679	CbGeAlD
Decitabine—DNMT3A—testis—testicular cancer	0.0127	0.0603	CbGeAlD
Decitabine—DNMT1—Epigenetic regulation of gene expression—DNMT3L—testicular cancer	0.0121	0.0475	CbGpPWpGaD
Decitabine—DCK—embryo—testicular cancer	0.0108	0.0515	CbGeAlD
Decitabine—DNMT3A—DNA methylation—H2AFZ—testicular cancer	0.0107	0.0423	CbGpPWpGaD
Decitabine—DNMT1—gonad—testicular cancer	0.0106	0.0506	CbGeAlD
Decitabine—DCK—seminal vesicle—testicular cancer	0.0102	0.0484	CbGeAlD
Decitabine—DNMT3A—PRC2 methylates histones and DNA—H2AFZ—testicular cancer	0.00975	0.0384	CbGpPWpGaD
Decitabine—DNMT3A—RMTs methylate histone arginines—H2AFZ—testicular cancer	0.00923	0.0363	CbGpPWpGaD
Decitabine—DNMT3A—lymph node—testicular cancer	0.00917	0.0437	CbGeAlD
Decitabine—DNMT1—female gonad—testicular cancer	0.00863	0.0411	CbGeAlD
Decitabine—DNMT1—testis—testicular cancer	0.00765	0.0364	CbGeAlD
Decitabine—DCK—gonad—testicular cancer	0.00735	0.035	CbGeAlD
Decitabine—DNMT1—DNA methylation—H2AFZ—testicular cancer	0.00726	0.0285	CbGpPWpGaD
Decitabine—DNMT1—PRC2 methylates histones and DNA—H2AFZ—testicular cancer	0.00659	0.0259	CbGpPWpGaD
Decitabine—DNMT3A—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.00625	0.0246	CbGpPWpGaD
Decitabine—DCK—female gonad—testicular cancer	0.00597	0.0284	CbGeAlD
Decitabine—DNMT1—lymph node—testicular cancer	0.00555	0.0264	CbGeAlD
Decitabine—DNMT1—Retinoblastoma (RB) in Cancer—H2AFZ—testicular cancer	0.00554	0.0218	CbGpPWpGaD
Decitabine—DCK—testis—testicular cancer	0.00529	0.0252	CbGeAlD
Decitabine—DNMT1—NoRC negatively regulates rRNA expression—H2AFZ—testicular cancer	0.00487	0.0192	CbGpPWpGaD
Decitabine—DNMT1—Negative epigenetic regulation of rRNA expression—H2AFZ—testicular cancer	0.00476	0.0187	CbGpPWpGaD
Decitabine—DCK—Retinoblastoma (RB) in Cancer—H2AFZ—testicular cancer	0.00458	0.018	CbGpPWpGaD
Decitabine—DCK—Doxorubicin—Epirubicin—testicular cancer	0.00443	0.519	CbGdCrCtD
Decitabine—DNMT1—Epigenetic regulation of gene expression—H2AFZ—testicular cancer	0.00422	0.0166	CbGpPWpGaD
Decitabine—DCK—Epirubicin—Doxorubicin—testicular cancer	0.0041	0.481	CbGdCrCtD
Decitabine—DNMT3A—Chromatin modifying enzymes—H2AFZ—testicular cancer	0.00394	0.0155	CbGpPWpGaD
Decitabine—DCK—lymph node—testicular cancer	0.00384	0.0183	CbGeAlD
Decitabine—DNMT3A—Gene Expression—DNMT3L—testicular cancer	0.00299	0.0117	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—DNMT3L—testicular cancer	0.00202	0.00793	CbGpPWpGaD
Decitabine—DNMT3A—Gene Expression—H2AFZ—testicular cancer	0.00104	0.00411	CbGpPWpGaD
Decitabine—DNMT1—Gene Expression—H2AFZ—testicular cancer	0.000706	0.00278	CbGpPWpGaD
Decitabine—DCK—Metabolism—HPGDS—testicular cancer	0.000622	0.00244	CbGpPWpGaD
Decitabine—DCK—Metabolism—STK11—testicular cancer	0.000452	0.00178	CbGpPWpGaD
Decitabine—Rash—Dactinomycin—testicular cancer	0.000383	0.000726	CcSEcCtD
Decitabine—Decreased appetite—Etoposide—testicular cancer	0.000382	0.000724	CcSEcCtD
Decitabine—Diarrhoea—Ifosfamide—testicular cancer	0.00038	0.000722	CcSEcCtD
Decitabine—Pancytopenia—Doxorubicin—testicular cancer	0.00038	0.000722	CcSEcCtD
Decitabine—Renal failure—Epirubicin—testicular cancer	0.000379	0.00072	CcSEcCtD
Decitabine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000379	0.000719	CcSEcCtD
Decitabine—Body temperature increased—Cisplatin—testicular cancer	0.000379	0.000719	CcSEcCtD
Decitabine—Fatigue—Etoposide—testicular cancer	0.000379	0.000718	CcSEcCtD
Decitabine—Stomatitis—Epirubicin—testicular cancer	0.000376	0.000714	CcSEcCtD
Decitabine—Pain—Etoposide—testicular cancer	0.000376	0.000712	CcSEcCtD
Decitabine—Constipation—Etoposide—testicular cancer	0.000376	0.000712	CcSEcCtD
Decitabine—Urinary tract infection—Epirubicin—testicular cancer	0.000375	0.000712	CcSEcCtD
Decitabine—Neutropenia—Doxorubicin—testicular cancer	0.000375	0.00071	CcSEcCtD
Decitabine—Dysuria—Doxorubicin—testicular cancer	0.000375	0.00071	CcSEcCtD
Decitabine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000372	0.000706	CcSEcCtD
Decitabine—Haemoglobin—Methotrexate—testicular cancer	0.000372	0.000706	CcSEcCtD
Decitabine—Haemorrhage—Methotrexate—testicular cancer	0.00037	0.000702	CcSEcCtD
Decitabine—Pollakiuria—Doxorubicin—testicular cancer	0.00037	0.000702	CcSEcCtD
Decitabine—Dizziness—Ifosfamide—testicular cancer	0.000368	0.000697	CcSEcCtD
Decitabine—Pharyngitis—Methotrexate—testicular cancer	0.000367	0.000697	CcSEcCtD
Decitabine—Urinary tract disorder—Methotrexate—testicular cancer	0.000366	0.000694	CcSEcCtD
Decitabine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000365	0.000692	CcSEcCtD
Decitabine—Epistaxis—Epirubicin—testicular cancer	0.000364	0.000691	CcSEcCtD
Decitabine—Urethral disorder—Methotrexate—testicular cancer	0.000363	0.000688	CcSEcCtD
Decitabine—Weight decreased—Doxorubicin—testicular cancer	0.000362	0.000687	CcSEcCtD
Decitabine—Sinusitis—Epirubicin—testicular cancer	0.000362	0.000687	CcSEcCtD
Decitabine—Feeling abnormal—Etoposide—testicular cancer	0.000362	0.000686	CcSEcCtD
Decitabine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000361	0.000685	CcSEcCtD
Decitabine—Nausea—Dactinomycin—testicular cancer	0.00036	0.000684	CcSEcCtD
Decitabine—Pneumonia—Doxorubicin—testicular cancer	0.000359	0.000681	CcSEcCtD
Decitabine—Gastrointestinal pain—Etoposide—testicular cancer	0.000359	0.000681	CcSEcCtD
Decitabine—Infestation—Doxorubicin—testicular cancer	0.000357	0.000677	CcSEcCtD
Decitabine—Infestation NOS—Doxorubicin—testicular cancer	0.000357	0.000677	CcSEcCtD
Decitabine—Vomiting—Ifosfamide—testicular cancer	0.000354	0.000671	CcSEcCtD
Decitabine—Hypersensitivity—Cisplatin—testicular cancer	0.000353	0.00067	CcSEcCtD
Decitabine—Renal failure—Doxorubicin—testicular cancer	0.000351	0.000666	CcSEcCtD
Decitabine—Rash—Ifosfamide—testicular cancer	0.000351	0.000665	CcSEcCtD
Decitabine—Dermatitis—Ifosfamide—testicular cancer	0.00035	0.000664	CcSEcCtD
Decitabine—Urticaria—Etoposide—testicular cancer	0.000349	0.000662	CcSEcCtD
Decitabine—Haemoglobin—Epirubicin—testicular cancer	0.000348	0.000661	CcSEcCtD
Decitabine—Stomatitis—Doxorubicin—testicular cancer	0.000348	0.00066	CcSEcCtD
Decitabine—Abdominal pain—Etoposide—testicular cancer	0.000347	0.000658	CcSEcCtD
Decitabine—Body temperature increased—Etoposide—testicular cancer	0.000347	0.000658	CcSEcCtD
Decitabine—Urinary tract infection—Doxorubicin—testicular cancer	0.000347	0.000658	CcSEcCtD
Decitabine—Haemorrhage—Epirubicin—testicular cancer	0.000346	0.000657	CcSEcCtD
Decitabine—Eye disorder—Methotrexate—testicular cancer	0.000346	0.000656	CcSEcCtD
Decitabine—Hypoaesthesia—Epirubicin—testicular cancer	0.000345	0.000654	CcSEcCtD
Decitabine—Asthenia—Cisplatin—testicular cancer	0.000344	0.000652	CcSEcCtD
Decitabine—Pharyngitis—Epirubicin—testicular cancer	0.000344	0.000652	CcSEcCtD
Decitabine—Cardiac disorder—Methotrexate—testicular cancer	0.000344	0.000652	CcSEcCtD
Decitabine—Urinary tract disorder—Epirubicin—testicular cancer	0.000342	0.000649	CcSEcCtD
Decitabine—Oedema peripheral—Epirubicin—testicular cancer	0.000341	0.000647	CcSEcCtD
Decitabine—Connective tissue disorder—Epirubicin—testicular cancer	0.00034	0.000646	CcSEcCtD
Decitabine—Urethral disorder—Epirubicin—testicular cancer	0.00034	0.000644	CcSEcCtD
Decitabine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000338	0.000641	CcSEcCtD
Decitabine—Epistaxis—Doxorubicin—testicular cancer	0.000337	0.000639	CcSEcCtD
Decitabine—Angiopathy—Methotrexate—testicular cancer	0.000336	0.000637	CcSEcCtD
Decitabine—Sinusitis—Doxorubicin—testicular cancer	0.000335	0.000636	CcSEcCtD
Decitabine—Immune system disorder—Methotrexate—testicular cancer	0.000334	0.000634	CcSEcCtD
Decitabine—Mediastinal disorder—Methotrexate—testicular cancer	0.000334	0.000633	CcSEcCtD
Decitabine—Chills—Methotrexate—testicular cancer	0.000332	0.00063	CcSEcCtD
Decitabine—Nausea—Ifosfamide—testicular cancer	0.00033	0.000626	CcSEcCtD
Decitabine—Diarrhoea—Cisplatin—testicular cancer	0.000328	0.000622	CcSEcCtD
Decitabine—Alopecia—Methotrexate—testicular cancer	0.000327	0.000621	CcSEcCtD
Decitabine—Mental disorder—Methotrexate—testicular cancer	0.000324	0.000615	CcSEcCtD
Decitabine—Eye disorder—Epirubicin—testicular cancer	0.000324	0.000614	CcSEcCtD
Decitabine—Hypersensitivity—Etoposide—testicular cancer	0.000324	0.000614	CcSEcCtD
Decitabine—Malnutrition—Methotrexate—testicular cancer	0.000322	0.000611	CcSEcCtD
Decitabine—Erythema—Methotrexate—testicular cancer	0.000322	0.000611	CcSEcCtD
Decitabine—Haemoglobin—Doxorubicin—testicular cancer	0.000322	0.000611	CcSEcCtD
Decitabine—Cardiac disorder—Epirubicin—testicular cancer	0.000322	0.00061	CcSEcCtD
Decitabine—Haemorrhage—Doxorubicin—testicular cancer	0.000321	0.000608	CcSEcCtD
Decitabine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000319	0.000605	CcSEcCtD
Decitabine—Pharyngitis—Doxorubicin—testicular cancer	0.000318	0.000604	CcSEcCtD
Decitabine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000317	0.000601	CcSEcCtD
Decitabine—Oedema peripheral—Doxorubicin—testicular cancer	0.000316	0.000599	CcSEcCtD
Decitabine—Asthenia—Etoposide—testicular cancer	0.000315	0.000598	CcSEcCtD
Decitabine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000315	0.000598	CcSEcCtD
Decitabine—Angiopathy—Epirubicin—testicular cancer	0.000314	0.000596	CcSEcCtD
Decitabine—Urethral disorder—Doxorubicin—testicular cancer	0.000314	0.000596	CcSEcCtD
Decitabine—Immune system disorder—Epirubicin—testicular cancer	0.000313	0.000594	CcSEcCtD
Decitabine—Mediastinal disorder—Epirubicin—testicular cancer	0.000312	0.000592	CcSEcCtD
Decitabine—Back pain—Methotrexate—testicular cancer	0.000312	0.000591	CcSEcCtD
Decitabine—Chills—Epirubicin—testicular cancer	0.000311	0.00059	CcSEcCtD
Decitabine—Pruritus—Etoposide—testicular cancer	0.000311	0.000589	CcSEcCtD
Decitabine—Alopecia—Epirubicin—testicular cancer	0.000306	0.000581	CcSEcCtD
Decitabine—Vomiting—Cisplatin—testicular cancer	0.000305	0.000578	CcSEcCtD
Decitabine—Vision blurred—Methotrexate—testicular cancer	0.000304	0.000576	CcSEcCtD
Decitabine—Mental disorder—Epirubicin—testicular cancer	0.000304	0.000576	CcSEcCtD
Decitabine—Rash—Cisplatin—testicular cancer	0.000302	0.000573	CcSEcCtD
Decitabine—Dermatitis—Cisplatin—testicular cancer	0.000302	0.000573	CcSEcCtD
Decitabine—Malnutrition—Epirubicin—testicular cancer	0.000302	0.000572	CcSEcCtD
Decitabine—Erythema—Epirubicin—testicular cancer	0.000302	0.000572	CcSEcCtD
Decitabine—Diarrhoea—Etoposide—testicular cancer	0.0003	0.00057	CcSEcCtD
Decitabine—Eye disorder—Doxorubicin—testicular cancer	0.0003	0.000568	CcSEcCtD
Decitabine—Ill-defined disorder—Methotrexate—testicular cancer	0.000299	0.000567	CcSEcCtD
Decitabine—Anaemia—Methotrexate—testicular cancer	0.000298	0.000565	CcSEcCtD
Decitabine—Cardiac disorder—Doxorubicin—testicular cancer	0.000298	0.000564	CcSEcCtD
Decitabine—Back pain—Epirubicin—testicular cancer	0.000292	0.000553	CcSEcCtD
Decitabine—Angiopathy—Doxorubicin—testicular cancer	0.000291	0.000552	CcSEcCtD
Decitabine—Malaise—Methotrexate—testicular cancer	0.000291	0.000551	CcSEcCtD
Decitabine—Dizziness—Etoposide—testicular cancer	0.00029	0.000551	CcSEcCtD
Decitabine—Muscle spasms—Epirubicin—testicular cancer	0.00029	0.00055	CcSEcCtD
Decitabine—Immune system disorder—Doxorubicin—testicular cancer	0.00029	0.000549	CcSEcCtD
Decitabine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000289	0.000548	CcSEcCtD
Decitabine—Leukopenia—Methotrexate—testicular cancer	0.000288	0.000547	CcSEcCtD
Decitabine—Chills—Doxorubicin—testicular cancer	0.000288	0.000546	CcSEcCtD
Decitabine—Nausea—Cisplatin—testicular cancer	0.000285	0.00054	CcSEcCtD
Decitabine—Vision blurred—Epirubicin—testicular cancer	0.000284	0.000539	CcSEcCtD
Decitabine—Alopecia—Doxorubicin—testicular cancer	0.000283	0.000537	CcSEcCtD
Decitabine—Cough—Methotrexate—testicular cancer	0.000281	0.000533	CcSEcCtD
Decitabine—Mental disorder—Doxorubicin—testicular cancer	0.000281	0.000533	CcSEcCtD
Decitabine—Ill-defined disorder—Epirubicin—testicular cancer	0.00028	0.000531	CcSEcCtD
Decitabine—Vomiting—Etoposide—testicular cancer	0.000279	0.00053	CcSEcCtD
Decitabine—Erythema—Doxorubicin—testicular cancer	0.000279	0.000529	CcSEcCtD
Decitabine—Malnutrition—Doxorubicin—testicular cancer	0.000279	0.000529	CcSEcCtD
Decitabine—Anaemia—Epirubicin—testicular cancer	0.000279	0.000529	CcSEcCtD
Decitabine—Rash—Etoposide—testicular cancer	0.000277	0.000525	CcSEcCtD
Decitabine—Dermatitis—Etoposide—testicular cancer	0.000277	0.000525	CcSEcCtD
Decitabine—Headache—Etoposide—testicular cancer	0.000275	0.000522	CcSEcCtD
Decitabine—Chest pain—Methotrexate—testicular cancer	0.000274	0.00052	CcSEcCtD
Decitabine—Arthralgia—Methotrexate—testicular cancer	0.000274	0.00052	CcSEcCtD
Decitabine—Myalgia—Methotrexate—testicular cancer	0.000274	0.00052	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000272	0.000517	CcSEcCtD
Decitabine—Malaise—Epirubicin—testicular cancer	0.000272	0.000516	CcSEcCtD
Decitabine—Discomfort—Methotrexate—testicular cancer	0.000271	0.000514	CcSEcCtD
Decitabine—Leukopenia—Epirubicin—testicular cancer	0.00027	0.000512	CcSEcCtD
Decitabine—Back pain—Doxorubicin—testicular cancer	0.00027	0.000512	CcSEcCtD
Decitabine—Muscle spasms—Doxorubicin—testicular cancer	0.000268	0.000509	CcSEcCtD
Decitabine—Confusional state—Methotrexate—testicular cancer	0.000265	0.000503	CcSEcCtD
Decitabine—Cough—Epirubicin—testicular cancer	0.000263	0.000499	CcSEcCtD
Decitabine—Anaphylactic shock—Methotrexate—testicular cancer	0.000263	0.000499	CcSEcCtD
Decitabine—Vision blurred—Doxorubicin—testicular cancer	0.000263	0.000499	CcSEcCtD
Decitabine—Infection—Methotrexate—testicular cancer	0.000261	0.000496	CcSEcCtD
Decitabine—Nausea—Etoposide—testicular cancer	0.000261	0.000495	CcSEcCtD
Decitabine—Hypertension—Epirubicin—testicular cancer	0.00026	0.000494	CcSEcCtD
Decitabine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000259	0.000491	CcSEcCtD
Decitabine—Nervous system disorder—Methotrexate—testicular cancer	0.000258	0.000489	CcSEcCtD
Decitabine—Anaemia—Doxorubicin—testicular cancer	0.000258	0.000489	CcSEcCtD
Decitabine—Thrombocytopenia—Methotrexate—testicular cancer	0.000258	0.000489	CcSEcCtD
Decitabine—Chest pain—Epirubicin—testicular cancer	0.000257	0.000487	CcSEcCtD
Decitabine—Arthralgia—Epirubicin—testicular cancer	0.000257	0.000487	CcSEcCtD
Decitabine—Myalgia—Epirubicin—testicular cancer	0.000257	0.000487	CcSEcCtD
Decitabine—Anxiety—Epirubicin—testicular cancer	0.000256	0.000485	CcSEcCtD
Decitabine—Skin disorder—Methotrexate—testicular cancer	0.000255	0.000485	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000255	0.000484	CcSEcCtD
Decitabine—Discomfort—Epirubicin—testicular cancer	0.000254	0.000481	CcSEcCtD
Decitabine—Malaise—Doxorubicin—testicular cancer	0.000252	0.000477	CcSEcCtD
Decitabine—Anorexia—Methotrexate—testicular cancer	0.000251	0.000476	CcSEcCtD
Decitabine—Leukopenia—Doxorubicin—testicular cancer	0.00025	0.000474	CcSEcCtD
Decitabine—Confusional state—Epirubicin—testicular cancer	0.000248	0.000471	CcSEcCtD
Decitabine—Anaphylactic shock—Epirubicin—testicular cancer	0.000246	0.000467	CcSEcCtD
Decitabine—Oedema—Epirubicin—testicular cancer	0.000246	0.000467	CcSEcCtD
Decitabine—Hypotension—Methotrexate—testicular cancer	0.000246	0.000466	CcSEcCtD
Decitabine—Infection—Epirubicin—testicular cancer	0.000245	0.000464	CcSEcCtD
Decitabine—Cough—Doxorubicin—testicular cancer	0.000244	0.000462	CcSEcCtD
Decitabine—Nervous system disorder—Epirubicin—testicular cancer	0.000241	0.000458	CcSEcCtD
Decitabine—Thrombocytopenia—Epirubicin—testicular cancer	0.000241	0.000457	CcSEcCtD
Decitabine—Hypertension—Doxorubicin—testicular cancer	0.000241	0.000457	CcSEcCtD
Decitabine—Tachycardia—Epirubicin—testicular cancer	0.00024	0.000456	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00024	0.000455	CcSEcCtD
Decitabine—Skin disorder—Epirubicin—testicular cancer	0.000239	0.000454	CcSEcCtD
Decitabine—Insomnia—Methotrexate—testicular cancer	0.000238	0.000451	CcSEcCtD
Decitabine—Myalgia—Doxorubicin—testicular cancer	0.000238	0.000451	CcSEcCtD
Decitabine—Chest pain—Doxorubicin—testicular cancer	0.000238	0.000451	CcSEcCtD
Decitabine—Arthralgia—Doxorubicin—testicular cancer	0.000238	0.000451	CcSEcCtD
Decitabine—Anxiety—Doxorubicin—testicular cancer	0.000237	0.000449	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000236	0.000448	CcSEcCtD
Decitabine—Discomfort—Doxorubicin—testicular cancer	0.000235	0.000445	CcSEcCtD
Decitabine—Anorexia—Epirubicin—testicular cancer	0.000235	0.000445	CcSEcCtD
Decitabine—Dyspnoea—Methotrexate—testicular cancer	0.000235	0.000445	CcSEcCtD
Decitabine—Dyspepsia—Methotrexate—testicular cancer	0.000232	0.000439	CcSEcCtD
Decitabine—Hypotension—Epirubicin—testicular cancer	0.00023	0.000436	CcSEcCtD
Decitabine—Confusional state—Doxorubicin—testicular cancer	0.00023	0.000436	CcSEcCtD
Decitabine—Decreased appetite—Methotrexate—testicular cancer	0.000229	0.000434	CcSEcCtD
Decitabine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000228	0.000432	CcSEcCtD
Decitabine—Oedema—Doxorubicin—testicular cancer	0.000228	0.000432	CcSEcCtD
Decitabine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000227	0.000431	CcSEcCtD
Decitabine—Fatigue—Methotrexate—testicular cancer	0.000227	0.00043	CcSEcCtD
Decitabine—Infection—Doxorubicin—testicular cancer	0.000226	0.000429	CcSEcCtD
Decitabine—Pain—Methotrexate—testicular cancer	0.000225	0.000427	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000224	0.000425	CcSEcCtD
Decitabine—Nervous system disorder—Doxorubicin—testicular cancer	0.000223	0.000424	CcSEcCtD
Decitabine—Thrombocytopenia—Doxorubicin—testicular cancer	0.000223	0.000423	CcSEcCtD
Decitabine—Insomnia—Epirubicin—testicular cancer	0.000223	0.000422	CcSEcCtD
Decitabine—Tachycardia—Doxorubicin—testicular cancer	0.000222	0.000422	CcSEcCtD
Decitabine—Skin disorder—Doxorubicin—testicular cancer	0.000221	0.00042	CcSEcCtD
Decitabine—Dyspnoea—Epirubicin—testicular cancer	0.000219	0.000416	CcSEcCtD
Decitabine—Anorexia—Doxorubicin—testicular cancer	0.000217	0.000412	CcSEcCtD
Decitabine—Feeling abnormal—Methotrexate—testicular cancer	0.000217	0.000411	CcSEcCtD
Decitabine—Dyspepsia—Epirubicin—testicular cancer	0.000217	0.000411	CcSEcCtD
Decitabine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000215	0.000408	CcSEcCtD
Decitabine—Decreased appetite—Epirubicin—testicular cancer	0.000214	0.000406	CcSEcCtD
Decitabine—Hypotension—Doxorubicin—testicular cancer	0.000213	0.000404	CcSEcCtD
Decitabine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000213	0.000403	CcSEcCtD
Decitabine—Fatigue—Epirubicin—testicular cancer	0.000212	0.000403	CcSEcCtD
Decitabine—Constipation—Epirubicin—testicular cancer	0.00021	0.000399	CcSEcCtD
Decitabine—Pain—Epirubicin—testicular cancer	0.00021	0.000399	CcSEcCtD
Decitabine—Urticaria—Methotrexate—testicular cancer	0.000209	0.000396	CcSEcCtD
Decitabine—Abdominal pain—Methotrexate—testicular cancer	0.000208	0.000394	CcSEcCtD
Decitabine—Body temperature increased—Methotrexate—testicular cancer	0.000208	0.000394	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000208	0.000394	CcSEcCtD
Decitabine—Insomnia—Doxorubicin—testicular cancer	0.000206	0.000391	CcSEcCtD
Decitabine—Dyspnoea—Doxorubicin—testicular cancer	0.000203	0.000385	CcSEcCtD
Decitabine—Feeling abnormal—Epirubicin—testicular cancer	0.000203	0.000385	CcSEcCtD
Decitabine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000201	0.000382	CcSEcCtD
Decitabine—Dyspepsia—Doxorubicin—testicular cancer	0.0002	0.00038	CcSEcCtD
Decitabine—Decreased appetite—Doxorubicin—testicular cancer	0.000198	0.000376	CcSEcCtD
Decitabine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000197	0.000373	CcSEcCtD
Decitabine—Fatigue—Doxorubicin—testicular cancer	0.000196	0.000372	CcSEcCtD
Decitabine—Urticaria—Epirubicin—testicular cancer	0.000196	0.000371	CcSEcCtD
Decitabine—Pain—Doxorubicin—testicular cancer	0.000195	0.000369	CcSEcCtD
Decitabine—Constipation—Doxorubicin—testicular cancer	0.000195	0.000369	CcSEcCtD
Decitabine—Body temperature increased—Epirubicin—testicular cancer	0.000195	0.000369	CcSEcCtD
Decitabine—Abdominal pain—Epirubicin—testicular cancer	0.000195	0.000369	CcSEcCtD
Decitabine—Hypersensitivity—Methotrexate—testicular cancer	0.000194	0.000368	CcSEcCtD
Decitabine—Asthenia—Methotrexate—testicular cancer	0.000189	0.000358	CcSEcCtD
Decitabine—Feeling abnormal—Doxorubicin—testicular cancer	0.000188	0.000356	CcSEcCtD
Decitabine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000186	0.000353	CcSEcCtD
Decitabine—Pruritus—Methotrexate—testicular cancer	0.000186	0.000353	CcSEcCtD
Decitabine—Hypersensitivity—Epirubicin—testicular cancer	0.000181	0.000344	CcSEcCtD
Decitabine—Urticaria—Doxorubicin—testicular cancer	0.000181	0.000343	CcSEcCtD
Decitabine—Body temperature increased—Doxorubicin—testicular cancer	0.00018	0.000342	CcSEcCtD
Decitabine—Abdominal pain—Doxorubicin—testicular cancer	0.00018	0.000342	CcSEcCtD
Decitabine—Diarrhoea—Methotrexate—testicular cancer	0.00018	0.000341	CcSEcCtD
Decitabine—Asthenia—Epirubicin—testicular cancer	0.000177	0.000335	CcSEcCtD
Decitabine—Pruritus—Epirubicin—testicular cancer	0.000174	0.00033	CcSEcCtD
Decitabine—Dizziness—Methotrexate—testicular cancer	0.000174	0.00033	CcSEcCtD
Decitabine—Diarrhoea—Epirubicin—testicular cancer	0.000168	0.000319	CcSEcCtD
Decitabine—Hypersensitivity—Doxorubicin—testicular cancer	0.000168	0.000318	CcSEcCtD
Decitabine—Vomiting—Methotrexate—testicular cancer	0.000167	0.000317	CcSEcCtD
Decitabine—Rash—Methotrexate—testicular cancer	0.000166	0.000315	CcSEcCtD
Decitabine—Dermatitis—Methotrexate—testicular cancer	0.000166	0.000314	CcSEcCtD
Decitabine—Headache—Methotrexate—testicular cancer	0.000165	0.000313	CcSEcCtD
Decitabine—Asthenia—Doxorubicin—testicular cancer	0.000163	0.00031	CcSEcCtD
Decitabine—Dizziness—Epirubicin—testicular cancer	0.000163	0.000309	CcSEcCtD
Decitabine—Pruritus—Doxorubicin—testicular cancer	0.000161	0.000306	CcSEcCtD
Decitabine—Vomiting—Epirubicin—testicular cancer	0.000157	0.000297	CcSEcCtD
Decitabine—Nausea—Methotrexate—testicular cancer	0.000156	0.000296	CcSEcCtD
Decitabine—Diarrhoea—Doxorubicin—testicular cancer	0.000156	0.000296	CcSEcCtD
Decitabine—Rash—Epirubicin—testicular cancer	0.000155	0.000294	CcSEcCtD
Decitabine—Dermatitis—Epirubicin—testicular cancer	0.000155	0.000294	CcSEcCtD
Decitabine—Headache—Epirubicin—testicular cancer	0.000154	0.000293	CcSEcCtD
Decitabine—Dizziness—Doxorubicin—testicular cancer	0.000151	0.000286	CcSEcCtD
Decitabine—Nausea—Epirubicin—testicular cancer	0.000146	0.000277	CcSEcCtD
Decitabine—Vomiting—Doxorubicin—testicular cancer	0.000145	0.000275	CcSEcCtD
Decitabine—Rash—Doxorubicin—testicular cancer	0.000144	0.000272	CcSEcCtD
Decitabine—Dermatitis—Doxorubicin—testicular cancer	0.000143	0.000272	CcSEcCtD
Decitabine—Headache—Doxorubicin—testicular cancer	0.000143	0.000271	CcSEcCtD
Decitabine—Nausea—Doxorubicin—testicular cancer	0.000135	0.000257	CcSEcCtD
